Previous Article | Next Article 
Journal of Virology, July 1999, p. 6031-6040, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Induction of Adult T-Cell Leukemia-Like Lymphoproliferative
Disease and Its Inhibition by Adoptive Immunotherapy in
T-Cell-Deficient Nude Rats Inoculated with Syngeneic Human T-Cell
Leukemia Virus Type 1-Immortalized Cells
Takashi
Ohashi,1
Shino
Hanabuchi,1
Hirotomo
Kato,1,2
Yoshihiro
Koya,1
Fumiyo
Takemura,1,3
Katsuiku
Hirokawa,4
Takashi
Yoshiki,5
Yuetsu
Tanaka,6
Masahiro
Fujii,1,7 and
Mari
Kannagi1,3,*
Department of
Immunotherapeutics1 and Pathology and
Immunology,4 Tokyo Medical and Dental
University, Medical Research Division, and Department of
Veterinary Internal Medicine, Faculty of Agriculture, University of
Tokyo, Tokyo 113,2 CREST, Japan
Science and Technology Corporation, Saitama
332,3 Department of Pathology,
Hokkaido University School of Medicine, Sapporo
060,5 Department of Biosciences, School
of Science, Kitasato University, Kanagawa
228,6 and Department of Virology,
Niigata University School of Medicine, Niigata
951,7 Japan
Received 1 December 1998/Accepted 26 March 1999
Human T-cell leukemia virus type 1 (HTLV-1) has been shown to be
the etiologic agent of adult T-cell leukemia (ATL), but the in vivo
mechanism by which the virus causes the malignant transformation is
largely unknown. In order to investigate the mechanisms of HTLV-1
leukemogenesis, we developed a rat model system in which ATL-like
disease was reproducibly observed, following inoculation of various rat
HTLV-1-immortalized cell lines. When previously established cell lines,
F344-S1 and TARS-1, but not TART-1 or W7TM-1, were inoculated, systemic
multiple tumor development was observed in adult nude
(nu/nu) rats. FPM1 cells, newly established from a
heterozygous (nu/+) rat syngeneic to nu/nu
rats, caused transient tumors only at the injection site
in adult nu/nu rats, but could progressively grow in
newborn nu/nu rats and metastasize in lymph nodes.
The derivative cell line (FPM1-V1AX) serially passed through newborn
nu/nu rats acquired the potency to grow in adult
nu/nu rats. These results indicated that only some with additional changes but not all of the in vitro
HTLV-1-immortalized cell lines possessed in vivo
tumorigenicity. Using the syngeneic system, we further showed
the inhibition of tumor development by transferring splenic T
cells from immunized rats, suggesting the involvement of T
cells in the regression of tumors. This novel and reproducible nude rat
model of human ATL would be useful for investigation of
leukemogenesis and antitumor immune responses in HTLV-1 infection.
*
Corresponding author. Mailing address: Department of
Immunotherapeutics, Tokyo Medical and Dental University, Medical
Research Division, 1-5-45 Yushima, Bunkyo-Ku, Tokyo 113, Japan. Phone: 81 (3) 5803-5798. Fax: 81 (3) 5803-0235. E-mail:
kann.impt{at}med.tmd.ac.jp.
Journal of Virology, July 1999, p. 6031-6040, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Takayanagi, R., Ohashi, T., Yamashita, E., Kurosaki, Y., Tanaka, K., Hakata, Y., Komoda, Y., Ikeda, S., Tsunetsugu-Yokota, Y., Tanaka, Y., Shida, H.
(2007). Enhanced Replication of Human T-Cell Leukemia Virus Type 1 in T Cells from Transgenic Rats Expressing Human CRM1 That Is Regulated in a Natural Manner. J. Virol.
81: 5908-5918
[Abstract]
[Full Text]
-
Kobayashi, H., Ngato, T., Sato, K., Aoki, N., Kimura, S., Tanaka, Y., Aizawa, H., Tateno, M., Celis, E.
(2006). In vitro Peptide Immunization of Target Tax Protein Human T-Cell Leukemia Virus Type 1-Specific CD4+ Helper T Lymphocytes.. Clin. Cancer Res.
12: 3814-3822
[Abstract]
[Full Text]
-
Nomura, M., Ohashi, T., Nishikawa, K., Nishitsuji, H., Kurihara, K., Hasegawa, A., Furuta, R. A., Fujisawa, J.-i., Tanaka, Y., Hanabuchi, S., Harashima, N., Masuda, T., Kannagi, M.
(2004). Repression of Tax Expression Is Associated both with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Killing by Tax-Specific Cytotoxic T Lymphocytes and with Impaired Tumorigenicity in a Rat Model. J. Virol.
78: 3827-3836
[Abstract]
[Full Text]
-
Harashima, N., Kurihara, K., Utsunomiya, A., Tanosaki, R., Hanabuchi, S., Masuda, M., Ohashi, T., Fukui, F., Hasegawa, A., Masuda, T., Takaue, Y., Okamura, J., Kannagi, M.
(2004). Graft-versus-Tax Response in Adult T-Cell Leukemia Patients after Hematopoietic Stem Cell Transplantation. Cancer Res.
64: 391-399
[Abstract]
[Full Text]
-
Hasegawa, A., Ohashi, T., Hanabuchi, S., Kato, H., Takemura, F., Masuda, T., Kannagi, M.
(2003). Expansion of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Reservoir in Orally Infected Rats: Inverse Correlation with HTLV-1-Specific Cellular Immune Response. J. Virol.
77: 2956-2963
[Abstract]
[Full Text]
-
Ohashi, T., Hanabuchi, S., Suzuki, R., Kato, H., Masuda, T., Kannagi, M.
(2002). Correlation of Major Histocompatibility Complex Class I Downregulation with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Cytotoxic T-Lymphocyte Killing in a Rat Model. J. Virol.
76: 7010-7019
[Abstract]
[Full Text]
-
Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Hasegawa, A., Takemura, F., Masuda, T., Kannagi, M.
(2001). Regression of Human T-cell Leukemia Virus Type I (HTLV-I)-Associated Lymphomas in a Rat Model: Peptide-Induced T-Cell Immunity. JNCI J Natl Cancer Inst
93: 1775-1783
[Abstract]
[Full Text]
-
Hakata, Y., Yamada, M., Shida, H.
(2001). Rat CRM1 Is Responsible for the Poor Activity of Human T-Cell Leukemia Virus Type 1 Rex Protein in Rat Cells. J. Virol.
75: 11515-11525
[Abstract]
[Full Text]
-
Ohashi, T., Hanabuchi, S., Kato, H., Tateno, H., Takemura, F., Tsukahara, T., Koya, Y., Hasegawa, A., Masuda, T., Kannagi, M.
(2000). Prevention of Adult T-Cell Leukemia-Like Lymphoproliferative Disease in Rats by Adoptively Transferred T Cells from a Donor Immunized with Human T-Cell Leukemia Virus Type 1 Tax-Coding DNA Vaccine. J. Virol.
74: 9610-9616
[Abstract]
[Full Text]
-
Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Takemura, F., Hirokawa, K., Yoshiki, T., Yagita, H., Okumura, K., Kannagi, M.
(2000). Development of Human T-Cell Leukemia Virus Type 1-Transformed Tumors in Rats following Suppression of T-Cell Immunity by CD80 and CD86 Blockade. J. Virol.
74: 428-435
[Abstract]
[Full Text]